Esther Zwick-Wallasch

Person

Munchen, DE

People

Patents Grantslast 30 patents

Information Patent Grant
AXL antibodies
- Patent number 8,933,202
- Issue date Jan 13, 2015
- U3 Pharma GmbH
- Thore Hettmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heparin-binding epidermal growth factor-like growth factor binding...
- Patent number 8,828,382
- Issue date Sep 9, 2014
- U3 Pharma GmbH
- Mike Rothe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies directed to the mammalian EAG1 ion channel protein
- Patent number 7,910,100
- Issue date Mar 22, 2011
- Max-Planck-Gesellschaft zur Forderung der Wissen
- Walter Stühmer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
EGF receptor transactivation by G-protein-coupled receptors require...
- Patent number 7,632,645
- Issue date Dec 15, 2009
- Max-Planck-Gesellschaft zur Forderung der Wissenschaften E.V.
- Axel Ullrich
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
Heparin-Binding Epidermal Growth Factor-like Growth Factor Binding...
- Publication number 20160009796
- Publication date Jan 14, 2016
- U3 PHARMA GMBH
- ROTHE MIKE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AXL ANTIBODIES
- Publication number 20150152193
- Publication date Jun 4, 2015
- U3 PHARMA GMBH
- Thore HETTMANN
- G01 - MEASURING TESTING
Information Patent Application
Heparin-Binding Epidermal Growth Factor-like Growth Factor Binding...
- Publication number 20150056211
- Publication date Feb 26, 2015
- U3 PHARMA GMBH
- ROTHE MIKE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION OF HB-EGF BINDING PROTEIN AND EGFR INHIBITOR
- Publication number 20150037336
- Publication date Feb 5, 2015
- U3 PHARMA GMBH
- Esther Zwick Wallasch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Heparin-Binding Epidermal Growth Factor-like Growth Factor Binding...
- Publication number 20110110956
- Publication date May 12, 2011
- Amgen, Inc.
- Mike Rothe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AXL ANTIBODIES
- Publication number 20100330095
- Publication date Dec 30, 2010
- U3 PHARMA GMBH
- Thore Hettmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EGF RECEPTOR TRANSACTIVATION BY G-PROTEIN-COUPLED RECEPTORS REQUIRE...
- Publication number 20100048684
- Publication date Feb 25, 2010
- MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V.
- Axel Ullrich
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel Antibodies Directed to the Mammalian Eag1 Ion Channel Protein
- Publication number 20090028851
- Publication date Jan 29, 2009
- MAXPLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCH
- Walter Stuhmer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Esther Zwick-Wallasch

Person

Patents Grantslast 30 patents

AXL antibodies

Heparin-binding epidermal growth factor-like growth factor binding...

Antibodies directed to the mammalian EAG1 ion channel protein

EGF receptor transactivation by G-protein-coupled receptors require...

Patents Applicationslast 30 patents

Heparin-Binding Epidermal Growth Factor-like Growth Factor Binding...

AXL ANTIBODIES

Heparin-Binding Epidermal Growth Factor-like Growth Factor Binding...

COMBINATION OF HB-EGF BINDING PROTEIN AND EGFR INHIBITOR

Heparin-Binding Epidermal Growth Factor-like Growth Factor Binding...

AXL ANTIBODIES

EGF RECEPTOR TRANSACTIVATION BY G-PROTEIN-COUPLED RECEPTORS REQUIRE...

Novel Antibodies Directed to the Mammalian Eag1 Ion Channel Protein